U.S. Markets open in 47 mins
S&P Futures
4,163.50+1.00(+0.02%)Dow Futures
33,933.00+10.00(+0.03%)Nasdaq Futures
14,014.25+0.25(+0.00%)
Veeva Systems Inc. (VEEV)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
275.82+7.53 (+2.81%)
At close: 4:00PM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 268.29 |
| Open | 272.00 |
| Bid | 268.80 x 1300 |
| Ask | 277.80 x 1000 |
| Day's Range | 272.00 - 277.20 |
| 52 Week Range | 152.24 - 325.54 |
| Volume | 624,876 |
| Avg. Volume | 1,003,588 |
| Market Cap | 41.986B |
| Beta (5Y Monthly) | 0.72 |
| PE Ratio (TTM) | 116.87 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- PR Newswire
Parexel and Veeva Partner to Accelerate Clinical Trials
Parexel and Veeva Systems (NYSE: VEEV) today announced a strategic collaboration to accelerate clinical trials through technology and process innovation. The unique collaboration combines the best of each company's experience across thousands of studies worldwide – Parexel as a leading clinical research organization (CRO) and Veeva as the technology innovator powering trials – to improve study efficiency and get new therapies to patients faster.
- Business Wire
TFS HealthScience Standardizes on Veeva Vault Clinical Operations Suite to Accelerate Clinical Development
Global CRO takes action to further modernize study operations, adopting the Veeva Vault Clinical Operations Suite for greater efficiency and speed.
- Business Wire
Boehringer Ingelheim Makes Rapid Shift to Digital Engagement with Veeva CRM Engage Meeting
Boehringer Ingelheim is standardizing on Veeva CRM Engage Meeting to drive more valued interactions between its global field organization and HCPs.
© 2021 Verizon Media. All rights reserved.
